Wednesday, October 2, 2019

Israeli chatbot could diagnose early Alzheimer’s disease

Hundreds of medicine are developed to handle Alzheimer’s disease, says Dr. Shahar Arzy, director of the computational neuropsychiatry laboratory at Hadassah Hebrew University Medical Center in Jerusalem. “Do you recognize what number are found effective? Zero.”But if patients could be diagnosed in the preclinical stages of the disease, perhaps some of the new biological medications showing excellent results in other domains of neurology could be effective when applied early enough in the course of Alzheimer’s disease.Arzy and his colleagues have developed a computer-based system to discover early signs of Alzheimer’s.Clara then uses machine learning to compare that information to a baseline so as to get a computer-based test tailored for the individual person who will diagnose every early Alzheimer’s.

Arzy’s team published research results in the Proceedings of the National Academy of Sciences and in the American Psychological Association’s journal Neuropsychology showing the method to be 95 percent accurate.Arzy's group published research results in the Proceedings of the National Academy of Sciences and in the American Psychological Association's journal Neuropsychology demonstrating the technique to be 95 percent exact.

For example, a patient may recollect both the death of US President John F. Kennedy and the appointment of Barack Obama however be confused about which came first. Or then again a patient may perceive their companion and specialist, however not have the option to recognize which individual is standing nearer.

Sunday, September 29, 2019

Memory loss-reversing electromagnetic cap could be Alzheimer’s breakthrough


Experimental #transcranial electromagnetic treatment (TEMT) involves wearing a skullcap and allowing it to break down the buildup of proteins in the #brain. They stop #nerve cells from functioning properly, resulting in #memory loss and other symptoms of #Alzheimer’s


For more details: Click here

Friday, September 27, 2019

Alzheimers Congress 2020

"12th World Congress On Alzheimers Disease and Dementia" on January 23-24,2020 at Bangkok ,Thailand.
#neurology#neuroscience#braindisorders#cognitivehealth#clinicalneuroscience
                       

For details, visit: https://bit.ly/2pPKqtN






Tuesday, September 24, 2019

Alzheimers Congress 2020

About Conference



ConferenceSeries LLC Ltd invites every one throughout the world to attend the “12th World Congress on Alzheimer's Disease and Dementia” during January 23-24, 2020 at Bangkok, Thailand which includes Keynote speeches, Oral talks, Poster presentations, and Exhibitions.
Alzheimer's disease (AD), also mentioned as Alzheimer's, is an enduring neurodegenerative disease that usually starts slowly and worsens over time. The most common early symptom of Alzheimer's is difficulty memorizing newly learned information because Alzheimer's changes naturally initiate in the part of the brain that affects learning. As Alzheimer's spreads through the brain, it leads to increasingly severe symptoms, including confusion, mood and behavior changes; deepening misperception about events, time and place; unfounded suspicions about family, friends and professional caregivers; more serious memory loss and behavior changes; and difficulty speaking, swallowing and walking.
Around the world, no less than 44 million individuals are living with dementia this number is believed to get double by 2030 and more than triple by 2050 to 115 million. A significant part of the expansion will be in creating nations like Western Europe and North America. Officially 62% of individuals with dementia live in creating nations. Today, more than 35 million individuals overall, are currently living with this condition.
Alzheimer’s Disease is complex, and it is doubtful that any one drug or other intervention can effectively treat it. Alzheimer’s has no current cure, but treatments for symptoms are available and research continues. In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy nearly $300 billion every year. All inclusive, dementia cost $600 billion a year.

The scope of the Conference

Alzheimer’s Congress 2020 provides a great platform by gathering eminent professors, researchers, students, and delegates to exchange new ideas.  The conference will cover a wide range of topics and allow participants to discuss the management of diseases. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world Conference Series LLC Ltd is offering reduced registration fee for students.

Conference Highlights

  • Alzheimers disease and Dementia
  • Vascular Dementia
  • Dementia with Lewy Bodies
  • Managing Dementia
  • Imaging Techniques
  • Pathophysiology and Disease Mechanism
  • Geriatric and Cognitive Disorder
  • Animal models and Translational Medicine
  • Current Research in Therapeutic Targets
  • Care Practice and Awareness
  • Behavioral Problems in Alzheimers disease
  • Insulin Resistance on the development of Alzheimers disesase
  • Frontotemporal Dementia
  • Neurological Diseases
  • Neurodegenerative Diseases
  • Alzheimers Disease and Type 2 Diabetes
 

Conference Opportunities For -

Researchers and Faculty Members:
  • Speaker Presentations
  • Poster Display
  • Symposium hosting (4-5 member team)
  • Workshop organizing
For Universities, Associations & Societies:
  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation
     
For Students and Research Scholars:
  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group registrations
For Business Delegates:
  • Speaker Presentations
  • Symposium hosting
  • Networking opportunities
For Product Manufacturers:
  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Marketing and Networking with clients
  • Workshop organizing
 

Why attend?

Alzheimer’s Congress 2020 will give a chance to all partners chipping away at Alzheimer's infection and Dementia to discuss their work. Alzheimer's Congress 2020 will assemble prestigious speakers, important examiners, specialists, neurologists and Dementia analysts from both scholarly community and social insurance industry will consolidate to talk about their perspectives and research. The gathering will be involved sessions by world-class specialists in the field of neurology. In Alzheimer’s Congress 2020, global symposiums, B2B gatherings, worldwide workshops will likewise be sorted out to talk about the particular points in the field of Alzheimer's Disease and Dementia and Neurology.

Conference Highlights



 Special Issues

  •  All accepted abstracts will be published in respective Supporting International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at https://alzheimersdementia.neurologyconference.com/